Annexon (ANNX) News Today $4.20 +0.09 (+2.19%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Annexon, Inc. (NASDAQ:ANNX) Sees Large Increase in Short InterestAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 8,980,000 shares, an increase of 23.7% from the December 15th total of 7,260,000 shares. Based on an average trading volume of 1,340,000 shares, the short-interest ratio is currently 6.7 days.January 16 at 7:43 AM | marketbeat.comBarclays PLC Acquires 120,789 Shares of Annexon, Inc. (NASDAQ:ANNX)Barclays PLC raised its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 212.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 177,765 shares of the company's stock after buying an additional 120,789 sharesJanuary 15 at 3:09 AM | marketbeat.comAnnexon announces 2025 strategic priorities, key catalystsJanuary 13, 2025 | markets.businessinsider.comAnnexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough YearJanuary 13, 2025 | markets.businessinsider.comAnnexon Expands Board with Appointment of New Member William JonesJanuary 13, 2025 | americanbankingnews.comJPMorgan Chase & Co. Has $10.10 Million Stake in Annexon, Inc. (NASDAQ:ANNX)JPMorgan Chase & Co. increased its position in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 16.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,706,182 shares of the company's stock after buying an addiJanuary 13, 2025 | marketbeat.comAnnexon Expands Board of Directors with Appointment of Commercial Executive William “BJ” JonesJanuary 10, 2025 | finance.yahoo.comAnnexon appoints William Jones to board of directorsJanuary 10, 2025 | markets.businessinsider.comAnnexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | globenewswire.comAnnexon (NASDAQ:ANNX) Stock Price Down 4.3% - What's Next?Annexon (NASDAQ:ANNX) Stock Price Down 4.3% - What's Next?January 6, 2025 | marketbeat.comGeode Capital Management LLC Grows Stake in Annexon, Inc. (NASDAQ:ANNX)Geode Capital Management LLC increased its holdings in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 18.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,143,635 shares of the company's stockDecember 31, 2024 | marketbeat.comBarclays PLC Has $1.05 Million Holdings in Annexon, Inc. (NASDAQ:ANNX)Barclays PLC boosted its stake in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 212.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 177,765 shares of the company's stock after buying an additional 120December 31, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have been given a consensus recommendation of "Buy" by the six research firms that are covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average twelve-month target price amongDecember 28, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Shares Purchased by State Street CorpState Street Corp raised its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 116.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,841,879 shares of the company's stock after purchasing an additional 2,068,2December 23, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Trading Down 3.8% - Here's WhyAnnexon (NASDAQ:ANNX) Stock Price Down 3.8% - Here's What HappenedDecember 19, 2024 | marketbeat.comPromising Real-World Evidence Boosts Buy Rating for Annexon’s ANX005 in GBS TreatmentDecember 18, 2024 | markets.businessinsider.comAnnexon's (ANNX) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $30.00 price target on shares of Annexon in a report on Tuesday.December 17, 2024 | marketbeat.comBuy Rating for Annexon Biosciences: ANX005 Shows Promising Results in GBS TreatmentDecember 17, 2024 | markets.businessinsider.comAnnexon Biosciences Positioned for Success with Promising ANX005 Study in GBSDecember 17, 2024 | markets.businessinsider.comAnnexon Announces Topline Data From RWE Study Of ANX005 For Guillain-Barré Syndrome, Stock UpDecember 16, 2024 | markets.businessinsider.comAnnexon Biosciences’ ANX005: Strong Buy Rating Backed by Promising Efficacy and Sales PotentialDecember 16, 2024 | markets.businessinsider.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)December 16, 2024 | globenewswire.comAnnexon (NASDAQ:ANNX) Shares Gap Up - Here's What HappenedAnnexon (NASDAQ:ANNX) Shares Gap Up - Still a Buy?December 16, 2024 | marketbeat.comAnnexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)December 16, 2024 | globenewswire.comCharles Schwab Investment Management Inc. Has $4.34 Million Stake in Annexon, Inc. (NASDAQ:ANNX)Charles Schwab Investment Management Inc. increased its position in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 221.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 732,216 shares of the company's stock after buying anDecember 14, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Stock Holdings Raised by Fmr LLCFmr LLC lifted its stake in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 3.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,561,949 shares of the company's stock after purchasing an additional 262,229 shares during the period. Fmr LLCDecember 8, 2024 | marketbeat.comPoint72 Asset Management L.P. Sells 662,019 Shares of Annexon, Inc. (NASDAQ:ANNX)Point72 Asset Management L.P. lessened its holdings in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 11.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,326,998 shares of the comDecember 6, 2024 | marketbeat.comAnnexon to present Phase 2 ARCHER DATA on ANX007December 5, 2024 | markets.businessinsider.comAnnexon, Inc. (NASDAQ:ANNX) Director Buys $17,056.00 in StockDecember 5, 2024 | insidertrades.comReadystate Asset Management LP Has $4.59 Million Holdings in Annexon, Inc. (NASDAQ:ANNX)Readystate Asset Management LP cut its holdings in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 12.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 774,860 shares of the company's stock after selling 108,588 shares duDecember 5, 2024 | marketbeat.comWalleye Capital LLC Purchases Shares of 328,698 Annexon, Inc. (NASDAQ:ANNX)Walleye Capital LLC purchased a new stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 328,698 shares of the company's stock, valued at approximately $1,946,000. WDecember 5, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Given Consensus Recommendation of "Buy" by BrokeragesShares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have been assigned a consensus rating of "Buy" from the six research firms that are currently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 1 year price objective among brokeragesDecember 3, 2024 | marketbeat.comSio Capital Management LLC Acquires Shares of 1,433,155 Annexon, Inc. (NASDAQ:ANNX)Sio Capital Management LLC bought a new position in Annexon, Inc. (NASDAQ:ANNX - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,433,155 shares of the company's stock, valNovember 29, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Shares Purchased by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA grew its holdings in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 9.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,160,886 shares of the company's stock after purchasiNovember 27, 2024 | marketbeat.comFY2027 Earnings Forecast for Annexon Issued By HC WainwrightAnnexon, Inc. (NASDAQ:ANNX - Free Report) - Stock analysts at HC Wainwright dropped their FY2027 EPS estimates for Annexon in a note issued to investors on Friday, November 15th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings per share of $0.49 for the year, downNovember 18, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Short Interest Down 12.9% in OctoberAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 7,770,000 shares, a decline of 12.9% from the October 15th total of 8,920,000 shares. Based on an average daily trading volume, of 1,270,000 shares, the days-to-cover ratio is presently 6.1 days.November 16, 2024 | marketbeat.comAnnexon Biosciences’ Promising Future: Buy Rating Backed by Strategic Decisions and Financial StabilityNovember 15, 2024 | markets.businessinsider.comAnnexon Biosciences: Promising Phase 3 Results and Pipeline Potential Justify Buy RatingNovember 15, 2024 | markets.businessinsider.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)November 15, 2024 | globenewswire.comAnnexon's (ANNX) Overweight Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating on shares of Annexon in a research report on Friday.November 15, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Given "Buy" Rating at Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and issued a $16.00 price target on shares of Annexon in a research note on Friday.November 15, 2024 | marketbeat.comAnnexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated MilestonesNovember 14, 2024 | globenewswire.comAnnexon Biosciences to Present at the Jefferies London Healthcare ConferenceNovember 13, 2024 | globenewswire.comAnnexon, Inc. (NASDAQ:ANNX) Receives Average Recommendation of "Buy" from BrokeragesShares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have received an average recommendation of "Buy" from the six research firms that are currently covering the stock, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price objective amoNovember 8, 2024 | marketbeat.comTD Cowen Reaffirms Their Buy Rating on Annexon Biosciences (ANNX)October 24, 2024 | markets.businessinsider.comAnnexon Reports Promising Phase 2 Data For ANX007 In Geographic Atrophy Due To Dry AMDOctober 22, 2024 | markets.businessinsider.comAnnexon presents Phase 2 Vision Preservation data with ANX007 in dry AMDOctober 22, 2024 | msn.comWe're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash WiselyOctober 21, 2024 | finance.yahoo.comAnnexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 MeetingOctober 21, 2024 | globenewswire.comInsider Selling: Annexon, Inc. (NASDAQ:ANNX) EVP Sells 5,408 Shares of StockOctober 18, 2024 | insidertrades.com Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address ANNX Media Mentions By Week ANNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANNX News Sentiment▼0.780.68▲Average Medical News Sentiment ANNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANNX Articles This Week▼73▲ANNX Articles Average Week Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CNTA News Today MESO News Today IDYA News Today AGIO News Today APGE News Today AMPH News Today IOVA News Today TARS News Today IRON News Today IBRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANNX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annexon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
